SE392104B - Forfarande for framstellning av ett bensfuranderivat - Google Patents

Forfarande for framstellning av ett bensfuranderivat

Info

Publication number
SE392104B
SE392104B SE7205672A SE567272A SE392104B SE 392104 B SE392104 B SE 392104B SE 7205672 A SE7205672 A SE 7205672A SE 567272 A SE567272 A SE 567272A SE 392104 B SE392104 B SE 392104B
Authority
SE
Sweden
Prior art keywords
furanda
benz
derivative
procedure
preparation
Prior art date
Application number
SE7205672A
Other languages
English (en)
Swedish (sv)
Inventor
F Binon
H Inion
Original Assignee
Labaz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz filed Critical Labaz
Publication of SE392104B publication Critical patent/SE392104B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
SE7205672A 1971-04-29 1972-04-28 Forfarande for framstellning av ett bensfuranderivat SE392104B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1227771 1971-04-29

Publications (1)

Publication Number Publication Date
SE392104B true SE392104B (sv) 1977-03-14

Family

ID=10001598

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7205672A SE392104B (sv) 1971-04-29 1972-04-28 Forfarande for framstellning av ett bensfuranderivat

Country Status (18)

Country Link
US (1) US3810991A (xx)
AR (1) AR192932A1 (xx)
AT (1) AT319243B (xx)
AU (1) AU456733B2 (xx)
BE (1) BE782604A (xx)
CA (1) CA971481A (xx)
CH (1) CH540930A (xx)
DE (1) DE2220361A1 (xx)
DK (1) DK139871B (xx)
ES (1) ES402285A1 (xx)
FR (1) FR2134435B1 (xx)
GB (1) GB1335403A (xx)
IE (1) IE36278B1 (xx)
NL (1) NL7205784A (xx)
NO (1) NO135788C (xx)
OA (1) OA04005A (xx)
SE (1) SE392104B (xx)
ZA (1) ZA722478B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851554A (en) * 1987-04-06 1989-07-25 University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4806663A (en) * 1987-04-06 1989-02-21 The University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4831156A (en) * 1987-09-30 1989-05-16 The University Of Tennessee Research Corp. 3-substituted 2-alkyl indole derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136620C (xx) * 1963-04-30
GB1245283A (en) * 1968-10-04 1971-09-08 Labaz Pyrazole derivatives

Also Published As

Publication number Publication date
DE2220361A1 (de) 1972-11-02
DK139871C (xx) 1979-10-08
FR2134435A1 (xx) 1972-12-08
GB1335403A (en) 1973-10-31
BE782604A (fr) 1972-10-25
AU456733B2 (en) 1974-12-06
AU4131872A (en) 1973-10-25
NL7205784A (xx) 1972-10-31
NO135788B (xx) 1977-02-21
CA971481A (en) 1975-07-22
AT319243B (de) 1974-12-10
AR192932A1 (es) 1973-03-21
ZA722478B (en) 1972-12-27
IE36278B1 (en) 1976-09-29
CH540930A (fr) 1973-08-31
FR2134435B1 (xx) 1976-04-16
IE36278L (en) 1972-10-29
NO135788C (xx) 1977-06-01
US3810991A (en) 1974-05-14
DK139871B (da) 1979-05-07
ES402285A1 (es) 1975-03-16
OA04005A (fr) 1979-09-15

Similar Documents

Publication Publication Date Title
SE432102B (sv) Forfarande for framstellning av estrar av penicilliner
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE401087B (sv) Forfarande for framstellning av ett antibakteriellt preparat innehallande penicillinderivat
SE435294B (sv) Forfarande for framstellning av ett sammansatt pigment
SE399064B (sv) Forfarande for framstellning av ett nytt dopaminderivat
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
SE384798B (sv) Forfarande for framstellning av ett laktulospulver
SE417207B (sv) Foerfarande foer framstaellning av en 3-metylencefalosporinfoerening
SE381397B (sv) Forfarande for framstellning av ett aromatiseringsmedel
SE382809B (sv) Forfarande for framstellning av fenoxiettiksyraderivat
SE417711B (sv) Forfarande for framstellning av 5-iminometyl-2-nitroimidazolderivat
DK143654C (da) Fremgangsmaade til fremstilling af et fluoranderivat af triphenylmethan
SE391332B (sv) Forfarande for framstellning av en fenyletanolamin
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE417318B (sv) Forfarande for framstellning av oxofurylesterderivat av penicillin
SE393376B (sv) Forfarande for framstellning av pyrimidinonderivat
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE400975B (sv) Forfarande for framstellning av ett nytt antibiotikum, benemnt 27 706 rp
SE395699B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE384197B (sv) Forfarande for tillverkning av ett stoppat foremal
SE409858B (sv) Forfarande for framstallning av vissa angivna aminoalkylfenylacetonitrilderivat
SE392104B (sv) Forfarande for framstellning av ett bensfuranderivat
SE405805B (sv) Forfarande for framstellning av ett sekretinpreparat med protraherad verkan
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE400979B (sv) Forfarande for framstellning av modifierade sampolymerer baserade pa ett cŸ1-cŸ4-alkylakrylat och en omettad flerbasisk karbonsyra anvendbara vid framstellning av lekemedel